WATER III Data is here! Come by the PROCEPT BioRobotics® booth E36 to learn more about the highly anticipated WATER III, investigator-led trial—comparing Aquablation® therapy vs. Transurethral laser enucleation for large prostates—that was unveiled at EAU 2025’s Game Changer session. This international multicenter study showed Aquablation therapy delivers: • Similar symptom score reduction to laser enucleation • Significantly lower rates of ejaculatory dysfunction (14.8% vs 77.1%) • Significantly lower stress incontinence (0% vs 9.1%) #Aquablation #BPH #GameChanger #EAU25 For safety information, please visit: https://bit.ly/48PsIM6
PROCEPT BioRobotics
3wAmazing